When to Perform Bladder Catheterization in Fast-track Hip and Knee Arthroplasty (POUR-RCT)

October 27, 2015 updated by: Lars Bjerregaard, Rigshospitalet, Denmark

Urinary Bladder Catheterization in Fast-track Hip and Knee Arthroplasty - What is the Optimal Bladder Volume? A Randomized, Controlled Study

Approximately 40 % of all patients undergoing fast-track total hip or knee arthroplasty needs intermittent bladder catheterization after surgery, as they are transient incapable of voluntary bladder emptying (postoperative urinary retention - POUR). The currently used interventional threshold for urinary bladder catheterization are a bladder volume of approximately 500 ml., but no evidence exists for this threshold. At the same time, the current knowledge suggest, that a bladder volume up to 1000 ml. for 2-4 hours are safe in humans, and as the use of urinary bladder catheterization are increasing the risk of complications, the investigators are hypothesizing that increasing the interventional threshold for urinary bladder catheterization after fast-track total hip or knee arthroplasty, will reduce the number of patients needing urinary bladder catheterization, without increasing the incidence of urological complications - including urinary tract infections.

Study Overview

Study Type

Interventional

Enrollment (Actual)

800

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Farsoe, Denmark, 9640
        • Aalborg University Hospital, Farsoe
      • Hellerup, Denmark, 2900
        • Department of Orthopaedics, Gentofte University Hospital
      • Vejle, Denmark, 7100
        • Department of Orthopaedics, Vejle Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 125 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • planned for elective total hip or knee arthroplasty
  • given written informed consent for participation

Exclusion Criteria:

  • can't co-operate to participation
  • can't speak or understand danish
  • preoperative use of urinary bladder catheterization
  • using haemodialysis
  • previous cystectomy
  • need for permanent urinary bladder catheter during surgery (decided by anaesthesiologist and/or surgeon)
  • Pregnant or given birth within the last 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 500 ml.
A bladder volume of 500 ml. or more, and incapability of voluntary micturition, is used as interventional threshold for urinary bladder catheterization.
Experimental: 800 ml
A bladder volume of 800 ml. or more, and incapability of voluntary micturition, is used as interventional threshold for urinary bladder catheterization.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of patients receiving postoperative urinary bladder catheterization
Time Frame: Patients will be followed from end of surgery to their first voluntary micturition, expectably within a mean period of twelve hours
Patients will be followed from end of surgery to their first voluntary micturition, expectably within a mean period of twelve hours

Secondary Outcome Measures

Outcome Measure
Time Frame
Incidence of urinary tract infections
Time Frame: within the first 30 days after surgery
within the first 30 days after surgery
Number of voiding difficulties acquired postoperatively
Time Frame: within the first 30 days postoperatively
within the first 30 days postoperatively
Number of readmissions due to urological issues (including urosepsis)
Time Frame: Within the first 30 days postoperatively
Within the first 30 days postoperatively

Other Outcome Measures

Outcome Measure
Time Frame
Time from last preoperative micturition to end of surgery.
Time Frame: Patients will be follwed from their last preoperative micturition to end of surgery. Expectably within a mean period of two hours.
Patients will be follwed from their last preoperative micturition to end of surgery. Expectably within a mean period of two hours.
Time from last preoperative micturitions to first postoperative bladder catheterization (if relevant).
Time Frame: Patients will be follwed from their last preoperative micturition to their first postoperative bladder catheterization (if relevant). Expectably within a mean period of six to eight hours.
Patients will be follwed from their last preoperative micturition to their first postoperative bladder catheterization (if relevant). Expectably within a mean period of six to eight hours.
Time from last preoperative micturition to first postoperative, voluntary micturition.
Time Frame: Patients will be follwed from their last preoperative micturition to their first postoperative, voluntary micturition. Expectably within a mean period of fourteen hours.
Patients will be follwed from their last preoperative micturition to their first postoperative, voluntary micturition. Expectably within a mean period of fourteen hours.
Time from end of surgery to first postoperative bladder catheterization (if relevant).
Time Frame: Patients will be follwed from end of surgery to their first postoperative bladder catheterization (if relevant). Expectably within a mean period of four to six hours.
Patients will be follwed from end of surgery to their first postoperative bladder catheterization (if relevant). Expectably within a mean period of four to six hours.
Time from end of surgery to first postoperative, voluntary micturition.
Time Frame: Patient will be followed from end of surgery to their first postoperative, voluntary micturition. Expectably within a mean period of twelve hours.
Patient will be followed from end of surgery to their first postoperative, voluntary micturition. Expectably within a mean period of twelve hours.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Lars Bjerregaard, MD, Rigshospitalet, Copenhagen University, Denmark

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Actual)

May 1, 2015

Study Completion (Actual)

May 1, 2015

Study Registration Dates

First Submitted

April 24, 2014

First Submitted That Met QC Criteria

April 29, 2014

First Posted (Estimate)

April 30, 2014

Study Record Updates

Last Update Posted (Estimate)

October 28, 2015

Last Update Submitted That Met QC Criteria

October 27, 2015

Last Verified

October 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Urinary Retention (POUR)

3
Subscribe